Narcolepsy Nightmare Study
Narcolepsy, Narcolepsy Type 1, Narcolepsy With Cataplexy
About this trial
This is an interventional treatment trial for Narcolepsy
Eligibility Criteria
Inclusion Criteria (all participants): Diagnosis of narcolepsy Age 18 or older Speak English Live in the United States Receiving standard medical care for narcolepsy Sleep and psychiatric medications stable for at least 3 months Nightmare frequency of ≥3 times per week Nightmare Disorder Index score indicates probable nightmare disorder Inclusion Criteria (Chicago area participants): Able to attend a study appointment in Evanston, IL Able and willing to not take wake-promoting medications on day of lab visit Exclusion Criteria: History of a neurological disorder that might alter EEG Currently engaged in sleep- or trauma-focused psychotherapy Previous behavioral treatment for nightmares Medical, psychiatric, or cognitive condition which would interfere with ability to engage in the treatment Untreated sleep apnea (AHI ≥ 5)
Sites / Locations
- Northwestern UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Imagery rehearsal therapy (IRT)
Imagery rehearsal therapy and targeted dream control (IRT+TDC)
Participants randomized to this group will receive 7 sessions of IRT.
Participants randomized to this group will receive 7 sessions of IRT+TDC.